Biopharma LLC

BioPharma Services Inc., a Think Research Subsidiary, Achieves Another Successful FDA Inspection Result

Retrieved on: 
Thursday, June 16, 2022
Clinical research, GLP, Electronic data capture, Pharmacist, GCP, Clinical trial, Bioanalysis, Bioequivalence, Digital, Therapy, Observation, Privacy, Medical writing, Compliance, CEO, Federal Food, Drug, and Cosmetic Act, Data management, Bed, Food, ANVISA, TSX Venture Exchange, EDC, Industry, FDA, Drug development, Achievement, View, EMR, EVP, Nursing, Health Canada, Standards Council of Canada, Failure, Good clinical practice, Contract research organization, Patient, Multimedia, Inspector, CRO, ANSM, Research, Company, CDISC, EMA, Biopharma LLC, FD, Commercial Operating System (COS), Judgement, Medical device, Pharmaceutical industry, Online shopping, Biostatistics

The successful results build on BioPharma's record of excellence with respect to regulatory audits conducted by the FDA.

Key Points: 
  • The successful results build on BioPharma's record of excellence with respect to regulatory audits conducted by the FDA.
  • BioPharma is leading the digitalization of the clinical research industry with its award-winning facilities in Toronto, Canada and St. Louis, USA.
  • Renzo DiCarlo, President of Clinical Research at BioPharmasaid, "This latest FDA inspection truly showcases BioPharma's commitment to provide robust, valuable data to our clients.
  • With an outstanding audit record spanning over 13 years, I'm so very proud of our Think Research Family."

DTG Launches Cleanroom PowerStation for GMP-Class Operations in Biopharma

Retrieved on: 
Wednesday, June 8, 2022
Other Manufacturing, Technology, Mobile, Wireless, Other Energy, Chemicals, Plastics, Manufacturing, Energy, Health, General Health, DTG, IEC, Good manufacturing practice, Time, Cleanroom, Founder, GMP, MES, Industry, Risk, Data management, LFP, Dust, Battery management system, Good, Manufacturing execution system, Documentation, Mobile phone, Biopharma LLC

DTG, the leading provider of industrial-strength power systems and mobile workstation solutions, today launched the Cleanroom PowerStation.

Key Points: 
  • DTG, the leading provider of industrial-strength power systems and mobile workstation solutions, today launched the Cleanroom PowerStation.
  • The Cleanroom PowerStation was first designed for one of the worlds leading biopharma firms to comply with its sterile environment requirements on the manufacturing line.
  • For this leading biopharma firm, the advanced battery system allows staff to remain in the cleanroom to perform manufacturing operations without having to leave to recharge a battery.
  • This reduces the risk of leaving and entering the cleanroom and potentially compromising cleanroom protocols each time.

Global Surgical Microscopes Market Analysis Report 2022: A $2.9 Billion Market by 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 25, 2022
Health, Surgery, Medical Supplies, Medical Devices, International, Hospital, Biopharma LLC, Danaher Corporation, ENT, Surgeon, Red reflex, Automation, USD, COVID-19, Nikon, Technology, Leica Microsystems, Alcon, Maintenance, GE Healthcare, CAGR, Ophthalmology, Application, Children's Hospital of Philadelphia, Dentistry, Pharmaceutical industry

The "Surgical Microscopes Market Size, Share & Trends Analysis Report by Type (On Casters, Wall Mounted, Tabletop), by Application, by End Use, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Surgical Microscopes Market Size, Share & Trends Analysis Report by Type (On Casters, Wall Mounted, Tabletop), by Application, by End Use, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global surgical microscopes market size is expected to reach USD 2.9 billion by 2030, growing at a CAGR of 11.37% from 2022 to 2030
    With the advent of surgical microscopes, it became easier for surgeons to perform such procedures more accurately in less time.
  • Emerging technologies such as wide-angle illumination, Red Reflex illumination, automation and augmented reality microscopy are expected to boost the market growth.
  • Carl Zeiss Meditec AG and Leica Microsystems (Danaher Corporation) are the major players in the surgical microscopes market.

RCH Introduces Scalable Cloud Service Offering for Growing Biotechs and Pharmas

Retrieved on: 
Wednesday, May 25, 2022
Biopharma LLC, Tim Riener, CSPS, Launch pad, RCH, Green Launching Pad, Adolescence, Environment, Goal, List of life sciences, Health care, Research, Time, Launch, AWS, Organization, Solution, Specialization, Cloud computing, Cloud engineering, CEO, IEEE Life Sciences, Video game console, Risk management, Management, Cloud, Google

WAYNE, Pa., May 25, 2022 /PRNewswire-PRWeb/ -- RCH Solutions, Inc. (RCH), a global provider of Bio-IT expertise for Life Sciences and Healthcare firms of all sizes, introduces RCH Launch Pad, a scalable, cost-effective Cloud computing service designed to address the unique compute challenges of start-up and growing organizations.

Key Points: 
  • The long-time provider of Bio-IT consultation and services introduces Launch Pada turnkey Cloud architecture and service implementation solution designed for adolescent and emerging biotechs and pharmas.
  • WAYNE, Pa., May 25, 2022 /PRNewswire-PRWeb/ -- RCH Solutions , Inc. (RCH), a global provider of Bio-IT expertise for Life Sciences and Healthcare firms of all sizes, introduces RCH Launch Pad , a scalable, cost-effective Cloud computing service designed to address the unique compute challenges of start-up and growing organizations.
  • "When operating a start-up or growing biopharma, speed, agility, and continuity are critical," said Michael Riener, president and CEO of RCH Solutions.
  • Additionally, RCH is vendor-agnostic, and can support platforms from a range of Cloud Service Providers (CSPs), including those offered by AWS , Google, and more.

Eagle Genomics Joins Nordic Medicon Valley Alliance

Retrieved on: 
Tuesday, May 24, 2022
Knowledge, University, Genome, Disease, Soil, Food and Nutrition Bulletin, Food, Climate change, Personal care, List of genetics research organizations, Biology, Medicon Valley Alliance, Science, Health, Workflow, Nordic, Biopharma LLC, Øresund Region, Research, Beauty, Food security, Microbiome, Genomics, Organization, Nutrition, Ecosystem, Fermentation, MVA, Growth, Water, CEO, Industrial design, Pharmaceutical industry, Antibiotics

CAMBRIDGE, England, May 24, 2022 /PRNewswire/ -- Eagle Genomics , the software business pioneering the application of network science to biology, has announced that it has joined Medicon Valley Alliance (MVA), a non-profit membership organization in the Danish-Swedish life science cluster in Medicon Valley.

Key Points: 
  • CAMBRIDGE, England, May 24, 2022 /PRNewswire/ -- Eagle Genomics , the software business pioneering the application of network science to biology, has announced that it has joined Medicon Valley Alliance (MVA), a non-profit membership organization in the Danish-Swedish life science cluster in Medicon Valley.
  • Anthony Finbow, CEO, Eagle Genomics, said:"We're pleased to be to join MVA, as we continue to grow and engage in pivotal multi-national partnerships and relationships.
  • Eagle Genomics is innovating at the intersection of biology, data sciences and bioinformatics, accelerating the generative economy through the digital reinvention of science.
  • Eagle Genomics is forging strategic relationships with leading scientific establishments focused on the microbiome and in the UK has helped shape the Microbiome Strategic Roadmap.

Eagle Genomics Joins Nordic Medicon Valley Alliance

Retrieved on: 
Tuesday, May 24, 2022
Knowledge, University, Genome, Disease, Soil, Food and Nutrition Bulletin, Food, Climate change, Personal care, List of genetics research organizations, Biology, Medicon Valley Alliance, Science, Health, Workflow, Nordic, Biopharma LLC, Øresund Region, Research, Beauty, Food security, Microbiome, Genomics, Organization, Nutrition, Ecosystem, Fermentation, MVA, Growth, Water, CEO, Industrial design, Pharmaceutical industry, Antibiotics

CAMBRIDGE, England, May 24, 2022 /PRNewswire/ -- Eagle Genomics , the software business pioneering the application of network science to biology, has announced that it has joined Medicon Valley Alliance (MVA), a non-profit membership organization in the Danish-Swedish life science cluster in Medicon Valley.

Key Points: 
  • CAMBRIDGE, England, May 24, 2022 /PRNewswire/ -- Eagle Genomics , the software business pioneering the application of network science to biology, has announced that it has joined Medicon Valley Alliance (MVA), a non-profit membership organization in the Danish-Swedish life science cluster in Medicon Valley.
  • Anthony Finbow, CEO, Eagle Genomics, said:"We're pleased to be to join MVA, as we continue to grow and engage in pivotal multi-national partnerships and relationships.
  • Eagle Genomics is innovating at the intersection of biology, data sciences and bioinformatics, accelerating the generative economy through the digital reinvention of science.
  • Eagle Genomics is forging strategic relationships with leading scientific establishments focused on the microbiome and in the UK has helped shape the Microbiome Strategic Roadmap.

Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis

Retrieved on: 
Tuesday, May 3, 2022
Antibody, Itch, Colitis, U.S. Securities and Exchange Commission, Standard of care, Week, AD, Private Securities Litigation Reform Act, Ulcerative colitis, Remission, Maintenance, Disability, GLOBE, UC, Company, CNTB, Safety, CA, Prevalence, Patient, Security (finance), Atopic dermatitis, Asthma, University, FDA, End organ damage, Dysplasia, Cancer, MD, Adult, Biopharma LLC, Lymphocyte, SEC, Terminology, Food and Drug Administration Amendments Act of 2007, News, CEO, Inflammation, SAN, Entrepreneurship, Connect, Progressive multifocal leukoencephalopathy, Medical imaging, Pharmaceutical industry, Vaccine, S1P1, Medicine

Additionally, reductions in lymphocyte counts amongst individuals receiving CBP-307 0.2 mg confirmed pharmacodynamic activity of CBP-307 in patients with active UC.

Key Points: 
  • Additionally, reductions in lymphocyte counts amongst individuals receiving CBP-307 0.2 mg confirmed pharmacodynamic activity of CBP-307 in patients with active UC.
  • The overall safety results in this study showed CBP-307 to be generally well tolerated in patients with moderate-to-severe UC.
  • These top-line, induction phase data demonstrate the potential for CBP-307 to provide benefit to patients living with moderate-to-severe UC, said Zheng Wei, Ph.D., Co-Founder and CEO of Connect Biopharma.
  • Connect Biopharma cautions that statements included in this press release that are not a description of historical facts are forward-looking statements.

Lunaphore deploys COMET™ at Propath UK

Retrieved on: 
Tuesday, May 3, 2022
Science, Other Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Genetics, Neuroscience, University, IHC, Neoplasm, Partnership, CRO, Biopharma LLC, Spatial analysis, Cros, Infection, Technology, Research, Fine chemical, Microscope, Medical imaging, Tourism

Lunaphore , a Swiss life sciences company developing technologies to enable spatial biology in every laboratory, today announced that it has deployed its COMET PA instrument at Propath UK , one of Europes leading contract research organizations (CRO).

Key Points: 
  • Lunaphore , a Swiss life sciences company developing technologies to enable spatial biology in every laboratory, today announced that it has deployed its COMET PA instrument at Propath UK , one of Europes leading contract research organizations (CRO).
  • Lunaphore and Propath UK will work closely to provide a flexible service that meets the needs of researchers across various disciplines.
  • We are delighted to form this partnership with Lunaphore and be able to offer our biopharmaceutical clients this highly innovative technology for spatial analysis, said Dr. Krish Soni, Chief Executive of Propath UK.
  • We are excited to partner with Propath UK to expand their spatial biology capabilities, said Ata Tuna Ciftlik, Chief Executive Officer at Lunaphore.

Theravance Biopharma to Report First Quarter 2022 Financial Results on May 5, 2022

Retrieved on: 
Monday, May 2, 2022
Name, Telephone, Maintenance, NASDAQ, Biopharma LLC, Patient, COPD, Chronic obstructive pulmonary disease, Webcast, Internet, FDA, Degenerative disease, GSK, IST, Investor, Pharmaceutical industry

DUBLIN, May 2, 2022 /PRNewswire/ --Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2022 financial results and provide a business update after market close on Thursday, May 5, 2022.

Key Points: 
  • DUBLIN, May 2, 2022 /PRNewswire/ --Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2022 financial results and provide a business update after market close on Thursday, May 5, 2022.
  • An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm ET (2:00 pm PT/10:00 pm IST) that day.
  • A replay of the conference call will be available on Theravance Biopharma's website for 30 days through June 4, 2022.
  • Theravance Biopharma, Inc.is a biopharmaceutical company primarily focused on the discovery, development and commercialization of respiratory medicines.

BIO-ISAC and New York Metro InfraGard Membership Alliance Announce Partnership

Retrieved on: 
Wednesday, April 27, 2022
Bioproducts, Gross domestic product, State bureau of investigation, Biotechnology, Information technology, Water, Software, Defense industrial base, Research, Food, National Academies of Sciences, Engineering, and Medicine, InfraGard, Board for International Food and Agricultural Development (BIFAD), Organization, Education, Federal Bureau of Investigation, Critical Manufacturing, New York metropolitan area, National academy, FBI, Ecosystem, Biopharma LLC, Partnership, Risk, Lawyer, Public health, Private sector, Risk management, Video game console, Engineering, Medicine, Agriculture, Chemical substance

NEW YORK, April 27, 2022 /PRNewswire/ --The Bioeconomy Information Sharing and Analysis Center (BIO-ISAC) and New York Metro InfraGard Members Alliance(NYM-IMA) today announced a partnership to address threats unique to the bioeconomy and enable coordination among stakeholders to facilitate a robust and secure industry.

Key Points: 
  • NEW YORK, April 27, 2022 /PRNewswire/ --The Bioeconomy Information Sharing and Analysis Center (BIO-ISAC) and New York Metro InfraGard Members Alliance(NYM-IMA) today announced a partnership to address threats unique to the bioeconomy and enable coordination among stakeholders to facilitate a robust and secure industry.
  • We look forward to developing our collaboration to further enhance, maintain and implement best practices and standards to improve global digital biosecurity."
  • *
    Jennifer Gold, president, NY Metro InfraGard said, "The digitization of life sciences has resulted in the emergence of a complex ecosystem plagued with cybersecurity challenges.
  • InfraGard is a partnership between the Federal Bureau of Investigation (FBI) and members of the private sector for the protection of U.S. Critical Infrastructure.